SAN FRANCISCO – A panel spanning regulator, payer, provider and academic interests celebrated the rapid proliferation of diagnostics based on emerging kinds of data that could enable more precise, earlier and better patient treatment. Starting with genomics, this data intensity has rapidly proliferated into all sorts of 'omics analyses, including proteomics, pharmacogenomics, metabolomics and microbiomics. Read More
SAN FRANCISCO – IBM Watson Health was a star at this year's J.P. Morgan Healthcare conference, announcing two deals with high profile players. The latest was with the U.S. FDA to work together to define a way for to exchange health data across a variety of technology platforms with an initial focus on oncology data. Read More
